{"DataElement":{"publicId":"2680653","version":"1","preferredName":"Donor Cellular Infusion Other Cell Therapy Administered Specify","preferredDefinition":"The free-text field to describe the donor cellular infusion other cells.","longName":"DCI_OTH_SPEC","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2680322","version":"1","preferredName":"Donor Cellular Infusion Other Cell","preferredDefinition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation._Different than the one(s) previously specified or mentioned. (NCI)_The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","longName":"DCI_CELL_OTH","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2793658","version":"1","preferredName":"Donor Cellular Infusion","preferredDefinition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation.","longName":"C77273","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Donor Cellular Infusion","conceptCode":"C77273","definition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"58D847F5-C148-4B1B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-09","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-10-09","modifiedBy":"ONEDATA","dateModified":"2008-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2680320","version":"1","preferredName":"Other Cell","preferredDefinition":"Not otherwise specified.:The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.","longName":"C17649:C12508","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39E01F92-B382-4ABC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-11","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-11","modifiedBy":"ONEDATA","dateModified":"2007-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"39E01F92-B393-4ABC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-11","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2179878","version":"1","preferredName":"Therapy Administered Specify","preferredDefinition":"the free-text field to specify the therapy administered.","longName":"TX_ADM_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208052","version":"1","preferredName":"Administered Specify","preferredDefinition":"Given.:Specify; be specific about something; define clearly.","longName":"C25382:C25685","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3B7A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0543273-E065-60FD-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-07","modifiedBy":"CAMPBELB","dateModified":"2005-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"2964925","version":"1","longName":"2450r1: Post-TED","context":"NHLBI"},{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"}]},{"publicId":"2842912","version":"1","longName":"Therapy","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2842913","version":"1","longName":"Best Response","context":"NHLBI"},{"publicId":"2842917","version":"1","longName":"Supportive","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"post_ted_dci_cll_oth_sp","type":"NMDP_FN","context":"NHLBI"},{"name":"dci_oth_cells_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"Product:typeCode","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"DCI: Type of cells -other- sp","type":"Preferred Question Text","description":"DCI: Type of cells -other- specify","url":null,"context":"NHLBI"},{"name":"Specify:","type":"Alternate Question Text","description":"Specify:","url":null,"context":"NHLBI"},{"name":"Specify cell type(s):","type":"Alternate Question Text","description":"Specify cell type(s):","url":null,"context":"NHLBI"},{"name":"Specify other cell type(s)","type":"Alternate Question Text","description":"Specify other cell type(s)","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2680653","type":"BRIDG Mapping Path","description":"\"[IF EXISTS THEN \"\"true\"\" ELSE \"\"false\"\"] PerformedProcedure > StudyAgent > Product.typeCode(CD).originalText WHERE PerformedProcedure > DefinedProcedure.nameCode = \"\"Administer Donor Cellular Infusion\"\" AND Product.typeCode(CD).nullFlavor = \"\"OTH\"\"\"","url":null,"context":"NHLBI"},{"name":"Specify:","type":"Application Standard Question Text","description":"Specify:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"39E2F14A-64C1-3CF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-11","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-11","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":"Added aqt \"Specify other cell type(s)\" for 2100r1 SW 3/4/10 System generated def displayed as alt def. AK 8/24/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}